The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specifications prior to shipment.There is no indication for a manufacturing-related failure.The evaluation of the returned sample confirmed that the deployment mechanism had been used and that the stent could not be deployed due to the breakage of a force transmitting component.Increased friction is considered the reason for increased release force and subsequent deployment failure.Potential factors that could have led or contributed to the reported event have been evaluated.Previous investigations of similar complaints have been reviewed.The reported event may be related to a difficult anatomy as highly tortuous or calcified vessels can lead to increased friction and subsequent release force increase.Reportedly, the target anatomy was calcified and a pre-dilation had been performed.The event also may be use-related as rough handling of the device can cause deformation and subsequent friction increase.In this case, no obvious deformation of the system was detected during evaluation.Based on the information available, a definite root cause for the reported event could not be determined.The ifu states: "examine the stent system for any damage.If it is suspected that the sterility or performance of the stent system has been compromised, the device must not be used." and "do not constrict the delivery system during stent deployment.If excessive force is felt during stent deployment, do not force the stent system.Remove the stent system and replace with a new unit.".
|